Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections

RT @jeroenlangereis: A collaboration with the department of pediatrics of the Radboudumc; A minireview on why IgG replacement therapy might…

RT @jeroenlangereis: A collaboration with the department of pediatrics of the Radboudumc; A minireview on why IgG replacement therapy might…

A collaboration with the department of pediatrics of the Radboudumc; A minireview on why IgG replacement therapy might not be sufficient to prevent respiratory tract infections in agammaglobulinemia patients and what kind of innovations are needed to do so

Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections https://t.co/iwGgsca2M8